Theresa Lowinus

Leipziger Str. 44
Magdeburg, ST 39120, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Molecular Tumor Boards in Malignant Melanoma: Uncovering Challenges and Opportunities in a Bicenter Retrospective Analysis in Germany.

Molecular Tumor Boards in Malignant Melanoma: Uncovering Challenges and Opportunities in a Bicenter Retrospective Analysis in Germany.

Journal: International journal of cancer

Published: December 18, 2025

Trop-2 expression in solid tumors : Expanded protein diagnostics within the molecular tumor board

Trop-2 expression in solid tumors : Expanded protein diagnostics within the molecular tumor board

Journal: Pathologie (Heidelberg, Germany)

Published: April 30, 2025

Immune-mediated colitis after immune checkpoint inhibitor therapy.

Immune-mediated colitis after immune checkpoint inhibitor therapy.

Journal: Trends in molecular medicine

Published: July 31, 2024

Adiponectin reduces immune checkpoint inhibitor-induced inflammation without blocking anti-tumor immunity.

Adiponectin reduces immune checkpoint inhibitor-induced inflammation without blocking anti-tumor immunity.

Journal: Cancer cell

Published: July 01, 2024

Proteasome inhibition potentiates Kv1.3 potassium channel expression as therapeutic target in drug-sensitive and -resistant human melanoma cells.

Proteasome inhibition potentiates Kv1.3 potassium channel expression as therapeutic target in drug-sensitive and -resistant human melanoma cells.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: July 07, 2023

Phase II trial of hypomethylating agent combined with nivolumab for acute myeloid leukaemia relapse after allogeneic haematopoietic cell transplantation-Immune signature correlates with response.

Phase II trial of hypomethylating agent combined with nivolumab for acute myeloid leukaemia relapse after allogeneic haematopoietic cell transplantation-Immune signature correlates with response.

Journal: British journal of haematology

Published: June 03, 2023

Targeting MDM2 enhances antileukemia immunity after allogeneic transplantation via MHC-II and TRAIL-R1/2 upregulation.

Targeting MDM2 enhances antileukemia immunity after allogeneic transplantation via MHC-II and TRAIL-R1/2 upregulation.

Journal: Blood

Published: February 24, 2022

Memantine potentiates cytarabine-induced cell death of acute leukemia correlating with inhibition of Kv1.3 potassium channels, AKT and ERK1/2 signaling.

Memantine potentiates cytarabine-induced cell death of acute leukemia correlating with inhibition of Kv1.3 potassium channels, AKT and ERK1/2 signaling.

Journal: Cell communication and signaling : CCS

Published: October 23, 2018

Immunomodulation by memantine in therapy of Alzheimer's disease is mediated through inhibition of Kv1.3 channels and T cell responsiveness.

Immunomodulation by memantine in therapy of Alzheimer's disease is mediated through inhibition of Kv1.3 channels and T cell responsiveness.

Journal: Oncotarget

Published: February 04, 2016

NMDA-receptor antagonists block B-cell function but foster IL-10 production in BCR/CD40-activated B cells.

NMDA-receptor antagonists block B-cell function but foster IL-10 production in BCR/CD40-activated B cells.

Journal: Cell communication and signaling : CCS

Published: April 30, 2014

Immunosuppression by N-methyl-D-aspartate receptor antagonists is mediated through inhibition of Kv1.3 and KCa3.1 channels in T cells.

Immunosuppression by N-methyl-D-aspartate receptor antagonists is mediated through inhibition of Kv1.3 and KCa3.1 channels in T cells.

Journal: Molecular and cellular biology

Published: December 18, 2013

Constitutive Akt1 signals attenuate B-cell receptor signaling and proliferation, but enhance B-cell migration and effector function.

Constitutive Akt1 signals attenuate B-cell receptor signaling and proliferation, but enhance B-cell migration and effector function.

Journal: European journal of immunology

Published: January 17, 2012

Showing 1-12 of 12

Last Updated: 09/26/2026